Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study

PLoS One. 2016 Jun 29;11(6):e0158398. doi: 10.1371/journal.pone.0158398. eCollection 2016.

Abstract

The objective of this study was to evaluate the varicella zoster virus (VZV) immunity in Iranian adolescents. It was conducted as a primary study for vaccine implementation, and to investigate the association of climatic and socioeconomic factors with the epidemiology of this infection. In this cross- sectional study, anti VZV antibodies were measured in serum samples obtained in a national school-based health survey (CASPIAN- III). Association of demographic, socio-economic, and climate of the living region with the frequency of VZV was investigated by multivariate multilevel analysis. Overall, sera of 2753 individuals aged 10-18 were tested for VZV antibodies, from those 87.4% were positive. The prevalence was statistically different in four socio-geographic regions (P<0.001), varying between 85.24% in West region (mostly mountainous areas with cold climate) to 94.59% in Southeast region (subtropical climate). Among variables studied, only age and mean daily temperature of the living area were positively associated with the VZV seroprevalence. Our findings show that most Iranians develop immunity to VZV before the age of 10, but a substantial proportion of them are yet susceptible to the infection. Therefore, it seems that the best strategy to reduce the burden of the disease is to vaccinate high- risk adults, i.e. those without a history of varicella infection. The regional temperature might be the only determinant of VZV epidemiology in Iran.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Antibodies, Viral / blood
  • Chickenpox / epidemiology*
  • Chickenpox / prevention & control
  • Child
  • Cross-Sectional Studies
  • Female
  • Geography
  • Herpesvirus 3, Human
  • Humans
  • Iran / epidemiology
  • Male
  • Multilevel Analysis
  • Risk Factors
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral

Grants and funding

This study was financially supported by Alborz University of Medical Sciences (project number: 2015.65.786) and Isfahan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.